Wagner J G
J Pharmacokinet Biopharm. 1975 Feb;3(1):51-67. doi: 10.1007/BF01066595.
The Loo-Reigelman absorption method provides the correct A infinity/V1 value and the correct rate constant ka (if absorption is first order), whether metabolism occurs in compartment 1 only, compartment 2 only, or both compartments 1 and 2 of the two-compartment open models. In cases where there is metabolism in compartment 2, the disposition parameters estimated from intravenous data are only apparent and not the real values. The correct A infinity/V1 and ka values are obtained, however, only under conditions not hithertofore specified. Thes conditions are that there must be essentially no bias in the disposition parameters k12, k21 and kel, and in the C0 value estimated from the intravenous data, and that in the oral study a large number of interpolated plasma concentrations, as well as the observed plasma concentrations, must be used, especially for drugs with long half-lives. It is shown that application of the Guggenheim method to the initial At/V1, t values frequently provides a better method of estimating A infinity/V1 and ka than the classical method. If biased disposition parameters are used in application of the Loo-Reigelman method oral data, then essentially the correct ovalue of ka will be estimated, but the estimate of A infinity/V1 will be approximately equal to the true value of A infinity/V1 multiplied by the ratio of the biased C0 value (obtained in fitting the intravenous data) to the true C0 value of the intravenous data. The above indicates that intravenous data should be fitted by computer until there are no systematic deviations or trends and as small a sum of squared deviations as possible is obtainedmthe oral data should be fitted by spline or Akima methods, or similar procedures, to produce a function which passes through each observed plasma concentration and at the same time provides a large number of interpolated concentration data.
对于二室开放模型,无论代谢仅发生在第1室、仅发生在第2室,还是同时发生在第1室和第2室,Loo-Reigelman吸收法均可提供正确的A∞/V1值和正确的速率常数ka(如果吸收为一级过程)。在第2室存在代谢的情况下,根据静脉注射数据估算的处置参数只是表观值而非真实值。然而,只有在迄今未明确规定的条件下才能获得正确的A∞/V1和ka值。这些条件是,处置参数k12、k21和kel以及根据静脉注射数据估算的C0值必须基本无偏差,并且在口服研究中,必须使用大量内插血浆浓度以及实测血浆浓度,对于半衰期长的药物尤其如此。结果表明,将Guggenheim法应用于初始At/V1、t值时,与经典方法相比,通常能更好地估算A∞/V1和ka。如果在应用Loo-Reigelman法处理口服数据时使用了有偏差的处置参数,那么本质上可以估算出正确的ka值,但A∞/V1的估算值将约等于A∞/V1的真实值乘以有偏差的C0值(在拟合静脉注射数据时获得)与静脉注射数据的真实C0值之比。上述情况表明,静脉注射数据应由计算机进行拟合,直至不存在系统偏差或趋势,并获得尽可能小的偏差平方和;口服数据应采用样条法或Akima法或类似程序进行拟合,以生成一个通过每个实测血浆浓度且同时提供大量内插浓度数据的函数。